您的位置: 首页 > 农业专利 > 详情页

IDENTIFICATION OF COMPROMISED COMPONENTS IN A MEDICAL SYSTEM
专利权人:
发明人:
Jonathon E. Giftakis,Timothy J. Denison,Paul H. Stypulkowski,Scott R. Stanslaski,Robert S. Raike,Mae Eng,David E. Linde,Thomas Adamski
申请号:
US15699873
公开号:
US20180071530A1
申请日:
2017.09.08
申请国别(地区):
US
年份:
2018
代理人:
摘要:
In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充